ChatGPT death lawsuit: Seattle woman dies after AI chatbot advised her to stop epilepsy medication

OpenAI's wrongful‑death lawsuit over a Seattle woman's fatal decision to taper her epilepsy medication after ChatGPT advised her to stop treatment underscores the growing legal risk tied to AI‑generated medical guidance. For website owners, this case highlights that any site hosting AI chat interfaces—or even linking to third‑party AI services—may be scrutinized for the accuracy of health information they convey. Regulators and users are increasingly demanding transparent disclosure of AI capabilities, especially when advice could affect medical outcomes. Failure to clearly label AI‑generated content or to restrict its scope can expose publishers to liability, damage reputation, and trigger bot‑traffic spikes from users seeking medical help. **Actionable steps:** 1. Update your llms.txt file to include a `Disallow: /chatbot` or similar rule for any endpoint that delivers health‑related responses, and add a `User‑Agent: *` directive stating “No medical advice permitted.” 2. Deploy real‑time AI‑bot monitoring (e.g., via llmscentral.com) to flag spikes in queries containing keywords like “epilepsy,” “medication,” or “taper,” enabling rapid response and content review. 3. Add explicit on‑page disclosures and a disclaimer that AI outputs are not professional medical advice, and implement rate‑limiting to deter misuse by individuals seeking health guidance.